159 related articles for article (PubMed ID: 36096312)
1. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial.
Poole S; Tanner AR; Naidu VV; Borca F; Phan H; Saeed K; Grocott MPW; Dushianthan A; Moyses H; Clark TW
J Infect; 2022 Dec; 85(6):625-633. PubMed ID: 36096312
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ; Beard KR; Malachira AK; Tanner AR; Sanga-Nyirongo L; Gwiggner M; Cummings JRF; Moyses HE; Clark TW
Lancet Infect Dis; 2023 Aug; 23(8):945-955. PubMed ID: 37116527
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
Clark TW; Beard KR; Brendish NJ; Malachira AK; Mills S; Chan C; Poole S; Ewings S; Cortes N; Nyimbili E; Presland L
Lancet Respir Med; 2021 Apr; 9(4):419-429. PubMed ID: 33285143
[TBL] [Abstract][Full Text] [Related]
4. INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care-study protocol for a multicentre randomised controlled trial.
High J; Enne VI; Barber JA; Brealey D; Turner DA; Horne R; Peters M; Dhesi Z; Wagner AP; Pandolfo AM; Stirling S; Russell C; O'Grady J; Swart AM; Gant V; Livermore DM;
Trials; 2021 Oct; 22(1):680. PubMed ID: 34620213
[TBL] [Abstract][Full Text] [Related]
5. Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Peiffer-Smadja N; Bouadma L; Mathy V; Allouche K; Patrier J; Reboul M; Montravers P; Timsit JF; Armand-Lefevre L
Crit Care; 2020 Jun; 24(1):366. PubMed ID: 32560662
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
[TBL] [Abstract][Full Text] [Related]
7. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
8. Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients.
Stafylaki D; Maraki S; Vaporidi K; Georgopoulos D; Kontoyiannis DP; Kofteridis DP; Chamilos G
Microbiol Spectr; 2022 Oct; 10(5):e0161622. PubMed ID: 36154180
[TBL] [Abstract][Full Text] [Related]
9. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
10. Rapid syndromic molecular testing in pneumonia: The current landscape and future potential.
Poole S; Clark TW
J Infect; 2020 Jan; 80(1):1-7. PubMed ID: 31809764
[TBL] [Abstract][Full Text] [Related]
11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
12. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
13. Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).
Serigstad S; Ritz C; Faurholt-Jepsen D; Markussen D; Ebbesen MH; Kommedal Ø; Bjørneklett RO; Heggelund L; Clark TW; van Werkhoven CH; Knoop ST; Ulvestad E; Grewal HMS;
Trials; 2022 Aug; 23(1):622. PubMed ID: 35915452
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial.
Shengchen D; Gu X; Fan G; Sun R; Wang Y; Yu D; Li H; Zhou F; Xiong Z; Lu B; Zhu G; Cao B
Clin Microbiol Infect; 2019 Nov; 25(11):1415-1421. PubMed ID: 31229593
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Khan RA; Aziz Z
Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
[TBL] [Abstract][Full Text] [Related]
16. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
Cartuliares MB; Rosenvinge FS; Mogensen CB; Skovsted TA; Andersen SL; Østergaard C; Pedersen AK; Skjøt-Arkil H
PLoS Med; 2023 Nov; 20(11):e1004314. PubMed ID: 38015833
[TBL] [Abstract][Full Text] [Related]
18. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ; Malachira AK; Armstrong L; Houghton R; Aitken S; Nyimbili E; Ewings S; Lillie PJ; Clark TW
Lancet Respir Med; 2017 May; 5(5):401-411. PubMed ID: 28392237
[TBL] [Abstract][Full Text] [Related]
19. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial.
Foucrier A; Roquilly A; Bachelet D; Martin-Loeches I; Bougle A; Timsit JF; Montravers P; Zahar JR; Eloy P; Weiss E;
BMJ Open; 2023 Feb; 13(2):e065293. PubMed ID: 36810173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
